“Medics currently have to rely on trial and error, meaning around half of the time the first type of antidepressant given fails to work. The researchers from King’s College London say checking a patient’s blood could help identify accurate treatment. Those who test positive for inflammation need more aggressive therapy from the outset, they say.”
“Marjorie Wallace from the mental health charity SANE said: “Being able to target those people with depression who don’t respond to medication would be one of the most exciting steps forward in the treatment of mental illness for decades.” Jenny Edwards of the Mental Health Foundation said: “If this test is as comprehensive and effective as thought then today’s news could mark a real sea-change in treatment.”
Read the full article: New blood test targets depression
Recent Posts
- The American Health Council Appoints Dr. James Bashkin, D.Phil. to the Physician Board March 31, 2020
- The American Health Council Appoints Dr. Robert W. Letton, MD to the Physician Board March 19, 2020
- The American Health Council Appoints Dr. Akwasi Adjei to the Industry Board January 17, 2020
- The American Health Council Appoints Dr. Nelson Leung to the Physician Board January 17, 2020
- The American Health Council Appoints Ms. Karie Soost to the Physician Board January 17, 2020
- The American Health Council Appoints Mr. Gregory King to the Industry Board January 17, 2020
